Often upregulated by lipolysis and obesity is Fabp4. Genetic deletion of Fabp4 eradicated obesity-associated mammary tumor growth and development (Hao et al., 2018), highlighting a potential biomarker to predict obesity-induced aggressiveness. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.